Hjem › Geografisk atrofi › Michigan
Geografisk atrofi kliniske forsøg i Michigan
5 studier for Geografisk atrofi søger deltagere på steder i Michigan.
Officiel studietekst (engelsk)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Foundation for Vision Research, Grand Rapids
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Associates of Michigan, Grand Blanc
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- University of Michigan Kellogg Eye Center, Ann Arbor
- Associated Retinal Consultants, P.C., Royal Oak
- Associated Retinal Consultants, P.C., Traverse City
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- University of Michigan Kellog Eye Center, Ann Arbor
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT03178149Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Oakland Ophthalmic Surgery, Birmingham
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.